Table 2. Tumor classifications applied to breast cancer datasets.
Classifications | Categories | Reference |
---|---|---|
Intrinsic Molecular
Subtype (IMS) |
Normal-like (Normal); HER2-enriched
(Her2); Basal-like (Basal); Luminal A (LumA); Luminal B (LumB); Claudin low (ClaudinLow) |
( Hu et al., 2006) |
Immune Benefit Status (IBS) | Immune Benefit-Enabled (IBE);
Immune Benefit-Disabled (IBD) |
(
Miller
et al., 2016;
Nagalla et al., 2013) |
Immunogenic
Disposition Status (IDS) |
Poor Immunogenic Disposition (PID);
Weak Immunogenic Disposition (WID); Favorable Immunogenic Disposition (FID) |
(
Miller
et al., 2016;
Nagalla et al., 2013) |
Immunologic Constant
of Rejection (ICR) |
ICR1; ICR2; ICR3; ICR4 | (
Galon
et al., 2013;
Hendrickx et al., 2017) |